The retention of infected cells in a wide variety of tissues, often with distinct viral and cellular
characteristics, underscores the importance of studying tissue reservoirs in the development
and assessment of cure strategies. Both inhibitory ARVs and latency-reversing drugs must
reach these sites, and novel strategies may be needed to attack virus in cells as variable as
T-follicular helper cells and macrophages.